Myxofibrosarcoma
| Myxofibrosarcoma | |
|---|---|
| Synonyms | Myxoid variant of malignant fibrous histiocytoma |
| Pronounce | N/A |
| Specialty | Oncology |
| Symptoms | Painless, slow-growing mass |
| Complications | N/A |
| Onset | Typically in older adults |
| Duration | Chronic |
| Types | Low-grade, intermediate-grade, high-grade |
| Causes | Unknown |
| Risks | Age, radiation therapy, genetic predisposition |
| Diagnosis | Biopsy, imaging studies |
| Differential diagnosis | Liposarcoma, fibrosarcoma, myxoid liposarcoma |
| Prevention | N/A |
| Treatment | Surgical resection, radiation therapy, chemotherapy |
| Medication | N/A |
| Prognosis | Variable, depends on grade and stage |
| Frequency | Rare |
| Deaths | N/A |
Myxofibrosarcoma is a type of malignant soft tissue sarcoma that is often found in the extremities of elderly adults, particularly in the legs. It is characterized by its myxoid (mucoid) appearance and the presence of fibroblasts, which are cells that produce collagen and other types of fibers.
Symptoms[edit]
The most common symptom of myxofibrosarcoma is a painless lump or swelling. As the tumor grows, it may cause pain or discomfort, particularly if it presses against nerves or muscles. Other symptoms can include fatigue, weight loss, and anemia, although these are less common.
Causes[edit]
The exact cause of myxofibrosarcoma is unknown. However, it is believed to be related to changes in the DNA of fibroblasts, which cause them to grow and divide uncontrollably. Some studies suggest that exposure to certain chemicals or radiation may increase the risk of developing this type of cancer, but more research is needed to confirm these findings.
Diagnosis[edit]
Diagnosis of myxofibrosarcoma typically involves a physical examination, imaging tests such as MRI or CT scan, and a biopsy of the tumor. The biopsy sample is examined under a microscope to confirm the presence of cancer cells and to determine the grade of the tumor, which indicates how aggressive the cancer is likely to be.
Treatment[edit]
Treatment for myxofibrosarcoma depends on the size, location, and grade of the tumor, as well as the patient's overall health. Options may include surgery to remove the tumor, radiation therapy to kill cancer cells, and chemotherapy to stop the growth of cancer cells. In some cases, a combination of these treatments may be used.
Prognosis[edit]
The prognosis for myxofibrosarcoma varies depending on a number of factors, including the grade of the tumor, the patient's age and overall health, and how well the cancer responds to treatment. In general, however, this type of cancer tends to be aggressive and has a high risk of recurrence.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
